Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

N/ACompletedNCT00978588

Yonsei University36 enrolled

Overview

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Mitral Valvular Heart Disease

Interventions

6% hydroxyethyl starch 130/0.4 and 5% albuminDRUG

Injection of 6% hydroxyethyl starch 130/0.4 and 5% albumin as priming solution for cardiopulmonary bypass

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * Mitral valvular heart disease Exclusion Criteria: * Status of Infection * Re-operation * Liver failure * Renal disease * Administration of steroid

Outcomes

Primary Outcomes

the pure effect of priming solutions

Time frame: after CPB

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.